Suchergebnisse - (Subject:"Tocilizumab")

PubPharm (6.673)

11

Tocilizumab for refractory post-COVID-19 pansclerotic morphea

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Saraswat, N. | Tripathy, D. | Mishra, A. | +3

12

Choosing immunomodulating therapies for the treatment of COVID-19 : recommendations based on placebo-controlled trial evidence

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2024

von Sweeney, D. | Lobo, S. | Póvoa, P. | +1

13

Evaluation of interleukin-1 and interleukin-6 receptor antagonists in a murine model of acute lung injury

enthalten in: Experimental physiology | 2024

von Meunier, �. | Aubin Vega, M. | Adam, D. | +6

14

Successful high-dose glucocorticoid therapy for anti-mitochondrial antibody-positive myocarditis arising during tocilizumab and low-dose glucocorticoid therapy for rheumatoid arthritis

enthalten in: Immunological medicine | 2024

von Suzuki, K. | Akiyama, M. | Saito, S. | +1

15

Impact of tocilizumab on anti-CD19 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia

enthalten in: Cancer | 2024

von Wang, X. | Zhang, B. | Zhang, Q. | +17

16

Study of various therapeutic strategies for the treatment of rapidly progressive periodontitis in experimental models

enthalten in: Journal of stomatology, oral and maxillofacial surgery | 2024

von Isakov, E. | Kalbaev, A. | Lobanchenko, O. | +1

17

Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study) : a multicenter, post-marketing, non-interventional, observational trial

enthalten in: Clinical rheumatology | 2024

von Athanassiou, P. | Katsimbri, P. | Bounas, A. | +23

18

TOCILIZUMAB RESOLVES REFRACTORY MACULAR EDEMA ASSOCIATED TO RETINITIS PIGMENTOSA

enthalten in: Retinal cases & brief reports | 2024

von Méndez-Martínez, S. | Pardiñas Barón, N. | Bartol-Puyal, F. | +6

19

Responsiveness to Tocilizumab in Anti-Acetylcholine Receptor-Positive Generalized Myasthenia Gravis

enthalten in: Aging and disease | 2024

von Jia, D. | Zhang, F. | Li, H. | +4

20

Comparative evaluation of tocilizumab and itolizumab for treatment of severe COVID-19 in India : a retrospective cohort study

enthalten in: Acute and critical care | 2024

von Kumar, A. | Kumar, N. | Pattanayak, A. | +4